1. Home
  2. ZYME vs RMIX Comparison

ZYME vs RMIX Comparison

Compare ZYME & RMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zymeworks Inc.

ZYME

Zymeworks Inc.

HOLD

Current Price

$22.81

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Suncrete Inc. Class A Common Stock

RMIX

Suncrete Inc. Class A Common Stock

N/A

Current Price

$17.68

Market Cap

1.4B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
ZYME
RMIX
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Building Materials
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2022
N/A

Fundamental Metrics

Financial Performance
Metric
ZYME
RMIX
Price
$22.81
$17.68
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
$38.90
N/A
AVG Volume (30 Days)
531.8K
280.3K
Earning Date
05-07-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
N/A
N/A
Revenue
$105,965,000.00
N/A
Revenue This Year
$183.10
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
38.87
N/A
52 Week Low
$11.86
$17.45
52 Week High
$29.75
$25.50

Technical Indicators

Market Signals
Indicator
ZYME
RMIX
Relative Strength Index (RSI) 36.89 32.58
Support Level $22.20 N/A
Resistance Level $23.66 $20.94
Average True Range (ATR) 0.92 1.33
MACD -0.30 -0.18
Stochastic Oscillator 1.07 7.36

Price Performance

Historical Comparison
ZYME
RMIX

About ZYME Zymeworks Inc.

Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.

About RMIX Suncrete Inc. Class A Common Stock

Suncrete Inc is a ready-mix concrete logistics and distribution platform operating across Oklahoma and Arkansas. Ready-mix concrete is a crucial building material that is used in the vast majority of infrastructure, commercial and residential construction projects. The company's ready-mix concrete business engages principally in the precise formulation, efficient production and on-time delivery of ready-mix concrete to the customers' job sites. It serves substantially all end markets of the construction industry in the select geographic markets. The company earns revenue prominently from the production and delivery of ready-mix concrete, with the majority revenue generated from orders under master purchase agreements or through direct sales to third-party contractors and suppliers.

Share on Social Networks: